CCN1 and ovarian carcinoma: Some studies have indicated that high expression of CYR61 was related to colorectal cancer [16], prostate cancer [17,18], ovarian cancer [19], glioma [20], osteosarcoma [21], gastric cancer [22] and breast cancer [23,24].